Sector revisions MBX Biosciences, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2026-04-17 pm EDT			5-day change	1st Jan Change
33.77 ^USD	+1.66%		+8.94%	+7.07%

Mar. 16	Mbx Biosciences Insider Bought Shares Worth $525,663, According to a Recent SEC Filing	MT
Mar. 12	MBX Biosciences, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. Revenue rev.	1y. Revenue rev.	Nbr of analysts
MBX BIOSCIENCES, INC.	-	-	-	11
LONZA GROUP AG				23
BEONE MEDICINES AG				26
REVOLUTION MEDICINES, INC.				20
CELLTRION, INC.				24
IQVIA HOLDINGS INC.				20
ASCENDIS PHARMA A/S				16
MEDPACE HOLDINGS, INC.				12
EUROFINS SCIENTIFIC SE				14
IONIS PHARMACEUTICALS, INC.				22
TEMPUS AI, INC.				15
ABIVAX				7
PRAXIS PRECISION MEDICINES, INC.				17
BIO-TECHNE CORPORATION				11
ICON PUBLIC LIMITED COMPANY				13
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.				15
QIAGEN N.V.				14
PHARMARON BEIJING CO., LTD.				12
KYMERA THERAPEUTICS, INC.				21
Average				16
Weighted average by Cap.				19